First OTC treatment for overactive bladder in women approved
Overactive
bladder is a condition that is characterized by leaking urine, feelings of
sudden and urgent need to urinate, and frequent urination. It affects about 33
million Americans, most of whom are older women. In January 2013, the U.S. Food
and Drug Administration approved the first over-the-counter (OTC) medication
available to treat overactive bladder. Oxytrol for Women was approved for OTC
use in women aged 18 years and older based on studies showing that women are
able to appropriately recognize symptoms of overactive bladder, decide if the
patch is right for them, and correctly and safely use the product. Oxytrol for
Women contains oxybutynin, which is an anticholinergic drug that helps relax
the bladder. The product is a topical patch that is applied to the skin every 4
days. Each patch delivers 3.9 mg of oxybutynin daily. Its reported side effects
are mild and include skin irritation where the patch is applied, dry mouth, and
constipation.
For men
with overactive bladder, the Oxytrol topical patch will continue to be
available by prescription only. The dose
of the prescription Oxytrol topical patch is the same as Oxytrol for Women
(oxybutynin 3.9 mg daily).
For
more information on Oxytrol for Women, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336815.htm
For
more information on overactive bladder, please visit: